How Can Antimicrobial Stewardship Best Practices Reduce Drug Resistance?

Drug resistance isn’t slowing down. Every time an antibiotic fails, we lose a tool we might need in emergencies. The problem isn’t that we don’t know how to stop it, we do. Pharmacist antimicrobial stewardship turns best practices into everyday actions that actually work.

Pharmacists sit at the critical intersection where antibiotics meet patients, giving them the unique ability to prevent unnecessary exposure before it happens. When pharmacists practice stewardship intentionally, resistance slows. When they don’t, resistance accelerates regardless of what doctors prescribe.

Daily Actions in Antimicrobial Stewardship Best Practices

Verification happens first. A pharmacist comparing every prescription against clinical guidelines catches errors that slip past rushed prescribers. They identify opportunities to de-escalate from broad-spectrum to narrow-spectrum antibiotics once culture results arrive.

Counseling comes next. Pharmacists explain why completing full courses matters and why skipping doses spreads resistance to others. They educate patients about viral infections that don’t need antibiotics, preventing unnecessary prescriptions before they start.

Beyond individual prescriptions, pharmacists take systematic action:

  • Audit facility patterns and identify resistance hotspots
  • Feed prescribing data back to doctors
  • Establish antibiotic guidelines specific to their region
  • Work with infection control teams to trace outbreaks

These daily practices transform pharmacies into stewardship hubs:

  • Participate in facility stewardship committees
  • Document antibiotic use trends
  • Flag drugs losing effectiveness
  • Recommend protocol adjustments based on data

This consistent approach, not sporadic interventions, actively reduces resistance development.

Pharmacist Role in Antibiotic Stewardship Across Two Healthcare Frontiers

Clinical Pharmacist Antimicrobial Stewardship in Hospital Settings

Inside hospitals, clinical pharmacists operate at the institutional level where stewardship decisions affect hundreds of patients daily.

Real-Time Prescription Review

Clinical pharmacists review prescriptions in real time, catching inappropriate use before antibiotics are administered. They participate in stewardship committees that set facility protocols and determine which antibiotics are available under what conditions.

Tracking Data and Flagging Trends

These pharmacists track antibiotic consumption data meticulously, watching which drugs are being used most frequently and why. They flag resistance trends as they emerge and adjust guidelines quarterly based on local patterns. This allows facilities to stay ahead of resistance rather than reacting to crises.

Responding to Resistant Organisms

When resistant organisms emerge, clinical pharmacists trace their spread through prescribing records. They identify which antibiotic classes are losing effectiveness and recommend interventions like restricting access or mandating infectious disease consultation before use.

Supporting Prescribers Daily

Prescribers sit beside doctors during ward rounds, offering alternatives when prescriptions seem excessive. They coordinate with laboratory teams to interpret culture results correctly. They recommend stopping prophylactic antibiotics after surgery when no longer needed. The clinical pharmacist’s role bridges best practices on paper and actual prescribing in patient care.

Community Pharmacist Antibiotic Stewardship in the Neighborhood

Outside hospitals, community pharmacist antibiotic stewardship happens in neighborhood pharmacies where most Nigerians access medications.

Refusing Inappropriate Sales

Community pharmacists encounter patients buying antibiotics without prescriptions, using leftovers, or requesting antibiotics for coughs. A trained community pharmacist refuses inappropriate sales and explains why the antibiotic won’t help. They offer alternatives like supportive care, rest, and symptom management instead.

Counseling and Patient Education

Community pharmacists counsel on correct antibiotic use when prescriptions are legitimate. They answer patient questions about side effects and interactions so patients feel confident following prescribing instructions. They help patients understand which conditions are treatable with antibiotics and which aren’t.

Reporting Resistance Patterns

Community pharmacists report resistance patterns they observe directly to health authorities or stewardship networks. When patients report that previous antibiotics didn’t work for similar symptoms, community pharmacists take notice. These observations inform regional surveillance and guide public health responses. By limiting inappropriate antibiotic use and providing education, community pharmacists directly reduce resistance development at the community level.

Building Effective Stewardship Programs

Facilities don’t stumble into effective pharmacist-led stewardship. It requires intentional structure. Successful programs start with institutional buy-in, leadership must recognize pharmacist stewardship as essential and allocate resources.

Implementation follows a practical roadmap:

  • Establish a stewardship committee with pharmacists, doctors, lab staff, and infection control
  • Define antibiotic guidelines specific to local resistance patterns
  • Create audit systems to track antibiotic use
  • Set up feedback loops where pharmacists report findings to prescribers
  • Develop patient education materials on appropriate use

The key is consistency. Sporadic stewardship sees minimal results. Embedded daily practice sees measurable change. Pharmacists need protected time for prescription review, rounds, and meetings, not squeezed around dispensing duties.

Training matters too. Pharmacists need knowledge of local resistance patterns, facility protocols, and communication skills. When these elements align, stewardship programs transform from theoretical to operational.

Pharmacist Expertise Unlocking Resistance Solutions

How can stewardship best practices reduce drug resistance? By recognizing pharmacists as essential, not supplementary. Clinical pharmacists verify institution-level decisions. Community pharmacists protect access points where patients encounter antibiotics. Both groups ensure antibiotics are used appropriately. 

NNAST has seen resistance slow dramatically in facilities where pharmacists practice stewardship at full capacity. The answer is empowering the professionals already positioned to change antibiotic use patterns every single day.

Scroll to Top
akinsete-omobosola-1004-240x240-29843

Dr. Omobosola Akinsete is a dedicated physician and a key member of the Nigerian Antimicrobial Stewardship Taskforce. She has been an internal medicine and adult Infectious Disease physician in the United States of America for 30  years . She graduated from Medical school at the University of Lagos, and has a masters in Public Health from Johns Hopkins school of Public Health. 

She did her Internal Medicine training at a Brown University hospital and her fellowship in Infectious Diseases  at the University of Minnesota where she is an associate professor. She has worked with the National Institutes of Health and Howard University a a coordinator for the Human Genome Project among other projects, she is a frequent public speaker and contributor to different types of media. She loves to advocate for healthcare in minority populations. She  has a lot of experience with  patients and health care providers on antimicrobial stewardship in her institution  HealthPartners in Minnesota U.S.A. Her expertise in the field of Infectious diseases and antimicrobial stewardship and her passion to improve health care in her home country will contribute significantly to the fight against antimicrobial resistance in Nigeria. Dr. Akinsete’s work with the taskforce focuses on leadership of the taskforce as chairperson and national coordinator, working closely with NCDC leadership, the Nigerian Federal Ministry of Health, stakeholders, and funding partners, and helping with capacity building of standardized antimicrobial stewardship and infectious disease educational programs. She will also use her expertise to guide providers and HealthCare institutions  on the ground . Her commitment to improving antimicrobial use and patient safety is invaluable to the nation’s public health efforts.